Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Metasphere Labs's Sloan Ratio for the quarter that ended in Jan. 2026 was 0.00%.
As of Jan. 2026, Metasphere Labs has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Metasphere Labs (OTCPK:LABZF) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Jan. 2026, Metasphere Labs has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
Metasphere Labs Sloan Ratio % Related Terms
Metasphere Labs Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Metasphere Labs's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LABZF vs MSFT, ORCL, PLTR: Sloan Ratio % Comparison
For the Software - Infrastructure subindustry, Metasphere Labs's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metasphere Labs Sloan Ratio % vs Software Industry
For the Software industry and Technology sector, Metasphere Labs's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Metasphere Labs's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Metasphere Labs's Sloan Ratio for the fiscal year that ended in Jul. 2025 is calculated as
Metasphere Labs's Net Income for the trailing twelve months (TTM) ended in Jan. 2026 was -0.155 (Apr. 2025 ) + -0.205 (Jul. 2025 ) + -0.081 (Oct. 2025 ) + -0.068 (Jan. 2026 ) = $-0.51 Mil.
Metasphere Labs's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jan. 2026 was -0.106 (Apr. 2025 ) + -0.06 (Jul. 2025 ) + -0.025 (Oct. 2025 ) + -0.023 (Jan. 2026 ) = $-0.21 Mil.
Metasphere Labs's Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2026 was 0 (Apr. 2025 ) + 0 (Jul. 2025 ) + 0 (Oct. 2025 ) + 0 (Jan. 2026 ) = $0.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metasphere Labs (LABZF) has a Sloan Ratio % of 0.00% as of Jan. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Metasphere Labs and its competitors.
Is Metasphere Labs' Sloan Ratio % too high?
Metasphere Labs' current Sloan Ratio % is 0.00%. Overall, Metasphere Labs has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Metasphere Labs' Sloan Ratio % compare to MSFT and ORCL?
Metasphere Labs' Sloan Ratio % of 0.00% can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Software company?
A good Sloan Ratio % depends on the Software industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Metasphere Labs and its competitors. Metasphere Labs's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metasphere Labs stock overvalued right now?
Based on GuruFocus' analysis, Metasphere Labs (LABZF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $0.17 — trading 769.5% above its estimated fair value. The current Sloan Ratio % is 0.00%. Metasphere Labs' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Metasphere Labs (LABZF), the current Sloan Ratio % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Metasphere Labs (LABZF) Overvalued in 2026?
Based on GuruFocus' analysis, Metasphere Labs stock appears to be overvalued.
The current stock price of $0.17 is trading 769.5% above its estimated GF Value™ of $0.02.
GuruFocus considers Metasphere Labs to be Significantly Overvalued.
Key valuation signals for LABZF:
Sloan Ratio %: 0.00%
GF Value™: $0.02 vs. price of $0.17 (769.5% above fair value)
No single metric tells the full story. See the LABZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Metasphere Labs Inc develops solutions for the metaverse, DAOs, gamification, and Web3, addressing social challenges related to climate change and aiming for a positive planetary impact. Its projects portfolio includes ClimateBot, and CarbonBot. Company operates in one single segment, which is the design, development, and sale of exclusive Non-Fungible Tokens. Its maximum revenue is from non-fungible tokens (NFT), with Geographical revenue from Canada.
29GF Score
Get the complete analysis for LABZF
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LABZF has been successfully added to your 
